Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
Condition(s):Hodgkin’s Disease; LymphomaLast Updated:January 5, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Hodgkin’s Disease; LymphomaLast Updated:January 5, 2018Completed
Condition(s):LymphomaLast Updated:April 22, 2022Completed
Condition(s):Leukaemia, Lymphocytic, Chronic and Lymphoma, FollicularLast Updated:November 17, 2017Completed
Condition(s):Mantle-Cell LymphomaLast Updated:July 21, 2016Completed
Condition(s):Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell LymphomaLast Updated:July 30, 2014Terminated
Condition(s):Mycosis FungoidesLast Updated:March 4, 2020Completed
Condition(s):B-cell LymphomaLast Updated:July 25, 2017Terminated
Condition(s):Breast Cancer; Lymphoma, Large B-Cell, Diffuse; Cardiotoxicity; Left Ventricular Dysfunction; Chemotherapy EffectLast Updated:February 23, 2023Active, not recruiting
Condition(s):LymphomaLast Updated:October 30, 2013Completed
Condition(s):Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma; Patients Treated With Rituximab-CHOP or Rituximab-CVPLast Updated:October 27, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.